David T. Rubin to Sulfasalazine
This is a "connection" page, showing publications David T. Rubin has written about Sulfasalazine.
Connection Strength
0.360
-
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr; 13(4):367-71.
Score: 0.290
-
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1346-50.
Score: 0.070